Therapeutic Potential of Microvesicles in Cell Therapy and Regenerative Medicine of Ocular Diseases With an Especial Focus on Mesenchymal Stem Cells-Derived Microvesicles

Overview

Journal Front Genet

Date 2022 Apr 15

PMID 35422841

Authors

Lina Moallemi Rad

Alexey V Yumashev

Bashdar Mahmud Hussen

Hazha Hadayat Jamad

Soudeh Ghafouri-Fard

Mohammad Taheri

Samaneh Rostami

Vahid Niazi

Mohammadreza Hajiesmaeili

Affiliations

Soon will be listed here.

Abstract

These days, mesenchymal stem cells (MSCs), because of immunomodulatory and pro-angiogenic abilities, are known as inevitable factors in regenerative medicine and cell therapy in different diseases such as ocular disorder. Moreover, researchers have indicated that exosome possess an essential potential in the therapeutic application of ocular disease. MSC-derived exosome (MSC-DE) have been identified as efficient as MSCs for treatment of eye injuries due to their small size and rapid diffusion all over the eye. MSC-DEs easily transfer their ingredients such as miRNAs, proteins, and cytokines to the inner layer in the eye and increase the reconstruction of the injured area. Furthermore, MSC-DEs deliver their immunomodulatory cargos in inflamed sites and inhibit immune cell migration, resulting in improvement of autoimmune uveitis. Interestingly, therapeutic effects were shown only in animal models that received MSC-DE. In this review, we summarized the therapeutic potential of MSCs and MSC-DE in cell therapy and regenerative medicine of ocular diseases.

Citing Articles

Mesenchymal Stem Cell-Sourced Exosomes as Potentially Novel Remedies for Severe Dry Eye Disease.

Harrell C, Djonov V, Volarevic A, Arsenijevic A, Volarevic V J Ophthalmol. 2025; 2025():5552374.

PMID: 39839752 PMC: 11748739. DOI: 10.1155/joph/5552374.

Bio-Inspired Nanocarriers Derived from Stem Cells and Their Extracellular Vesicles for Targeted Drug Delivery.

Abudurexiti M, Zhao Y, Wang X, Han L, Liu T, Wang C Pharmaceutics. 2023; 15(7).

PMID: 37514197 PMC: 10386614. DOI: 10.3390/pharmaceutics15072011.

Extracellular vesicles as biomarkers and modulators of atherosclerosis pathogenesis.

Patel S, Guo M, Abdul Samad M, Howe K Front Cardiovasc Med. 2023; 10:1202187.

PMID: 37304965 PMC: 10250645. DOI: 10.3389/fcvm.2023.1202187.

Extracellular vesicles as a new horizon in the diagnosis and treatment of inflammatory eye diseases: A narrative review of the literature.

Habibi A, Zarei-Behjani Z, Falamarzi K, Malekpour M, Ebrahimi F, Soleimani M Front Immunol. 2023; 14:1097456.

PMID: 36969177 PMC: 10033955. DOI: 10.3389/fimmu.2023.1097456.

Combined Application of Exosomes and FPR2 Agonist LXA4 in Controlling Fetal Membrane Inflammation and Promoting Fetal Membrane Tissue Repair.

Huang X, Liao J, Feng F, Chen S, Liao E, Li D Reprod Sci. 2022; 30(6):1979-1993.

PMID: 36525236 DOI: 10.1007/s43032-022-01148-x.

References

Phinney D, Prockop D . Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views. Stem Cells. 2007; 25(11):2896-902. DOI: 10.1634/stemcells.2007-0637. View

Zhang W, Dong X, Wang T, Kong Y . Exosomes derived from platelet-rich plasma mediate hyperglycemia-induced retinal endothelial injury via targeting the TLR4 signaling pathway. Exp Eye Res. 2019; 189:107813. DOI: 10.1016/j.exer.2019.107813. View

Niazi V, Ghafouri-Fard S, Verdi J, Jeibouei S, Karami F, Pourhadi M . Hypoxia preconditioned mesenchymal stem cell-derived exosomes induce ex vivo expansion of umbilical cord blood hematopoietic stem cells CD133+ by stimulation of Notch signaling pathway. Biotechnol Prog. 2021; 38(1):e3222. DOI: 10.1002/btpr.3222. View

Burrello J, Monticone S, Gai C, Gomez Y, Kholia S, Camussi G . Stem Cell-Derived Extracellular Vesicles and Immune-Modulation. Front Cell Dev Biol. 2016; 4:83. PMC: 4992732. DOI: 10.3389/fcell.2016.00083. View

Yamashita K, Inagaki E, Hatou S, Higa K, Ogawa A, Miyashita H . Corneal Endothelial Regeneration Using Mesenchymal Stem Cells Derived from Human Umbilical Cord. Stem Cells Dev. 2018; 27(16):1097-1108. DOI: 10.1089/scd.2017.0297. View

Lande K, Gupta J, Ranjan R, Kiran M, Solis L, Herrera A . Exosomes: Insights from Retinoblastoma and Other Eye Cancers. Int J Mol Sci. 2020; 21(19). PMC: 7582726. DOI: 10.3390/ijms21197055. View

Shen T, Zheng Q, Shen J, Li Q, Song X, Luo H . Effects of Adipose-derived Mesenchymal Stem Cell Exosomes on Corneal Stromal Fibroblast Viability and Extracellular Matrix Synthesis. Chin Med J (Engl). 2018; 131(6):704-712. PMC: 5865317. DOI: 10.4103/0366-6999.226889. View

Sivagurunathan S, Raman R, Chidambaram S . PIWI-like protein, HIWI2: A novel player in proliferative diabetic retinopathy. Exp Eye Res. 2018; 177:191-196. DOI: 10.1016/j.exer.2018.08.018. View

Stitt A, Curtis T, Chen M, Medina R, Mckay G, Jenkins A . The progress in understanding and treatment of diabetic retinopathy. Prog Retin Eye Res. 2015; 51:156-86. DOI: 10.1016/j.preteyeres.2015.08.001. View

10.

Shiboski S, Shiboski C, Criswell L, Baer A, Challacombe S, Lanfranchi H . American College of Rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken). 2012; 64(4):475-87. PMC: 3349440. DOI: 10.1002/acr.21591. View

11.

Liu H, Zhang J, Liu C, Hayashi Y, Kao W . Bone marrow mesenchymal stem cells can differentiate and assume corneal keratocyte phenotype. J Cell Mol Med. 2011; 16(5):1114-24. PMC: 4365890. DOI: 10.1111/j.1582-4934.2011.01418.x. View

12.

Crop M, Baan C, Weimar W, Hoogduijn M . Potential of mesenchymal stem cells as immune therapy in solid-organ transplantation. Transpl Int. 2008; 22(4):365-76. DOI: 10.1111/j.1432-2277.2008.00786.x. View

13.

Bora N, Matta B, Lyzogubov V, Bora P . Relationship between the complement system, risk factors and prediction models in age-related macular degeneration. Mol Immunol. 2014; 63(2):176-83. DOI: 10.1016/j.molimm.2014.07.012. View

14.

Biasutto L, Chiechi A, Couch R, Liotta L, Espina V . Retinal pigment epithelium (RPE) exosomes contain signaling phosphoproteins affected by oxidative stress. Exp Cell Res. 2013; 319(13):2113-2123. PMC: 3727419. DOI: 10.1016/j.yexcr.2013.05.005. View

15.

Mavragani C . Mechanisms and New Strategies for Primary Sjögren's Syndrome. Annu Rev Med. 2017; 68:331-343. DOI: 10.1146/annurev-med-043015-123313. View

16.

Ghosh A, Degyatoreva N, Kukielski C, Story S, Bhaduri S, Maiti K . Targeting miRNA by tunable small molecule binders: peptidic aminosugar mediated interference in miR-21 biogenesis reverts epithelial to mesenchymal transition. Medchemcomm. 2018; 9(7):1147-1154. PMC: 6072456. DOI: 10.1039/c8md00092a. View

17.

Bourne W . Biology of the corneal endothelium in health and disease. Eye (Lond). 2003; 17(8):912-8. DOI: 10.1038/sj.eye.6700559. View

18.

Caspi R . A look at autoimmunity and inflammation in the eye. J Clin Invest. 2010; 120(9):3073-83. PMC: 2929721. DOI: 10.1172/JCI42440. View

19.

Sene A, Chin-Yee D, Apte R . Seeing through VEGF: innate and adaptive immunity in pathological angiogenesis in the eye. Trends Mol Med. 2014; 21(1):43-51. PMC: 4282831. DOI: 10.1016/j.molmed.2014.10.005. View

20.

Gain P, Jullienne R, He Z, Aldossary M, Acquart S, Cognasse F . Global Survey of Corneal Transplantation and Eye Banking. JAMA Ophthalmol. 2015; 134(2):167-73. DOI: 10.1001/jamaophthalmol.2015.4776. View